E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/5/2010 in the Prospect News PIPE Daily.

New Issue: Lotus Pharmaceuticals gets $10 million equity commitment from YA Global

By Devika Patel

Knoxville, Tenn., March 5 - Lotus Pharmaceuticals, Inc. negotiated a $10 million two-year standby equity distribution agreement with YA Global Investments, LP on Wednesday, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company may sell stock in up to $200,000 tranches at 93% of the lowest daily volume-weighted average price of its common stock during the five consecutive trading days after the date the company provides an advance notice to YA Global, subject to a minimum price of $0.87.

YA Global also received 228,117 shares as a commitment fee of $300,000 in connection with the deal.

Lotus, based in Boca Raton, Fla., develops over-the-counter medications for distribution to the People's Republic of China.

Issuer:Lotus Pharmaceuticals, Inc.
Issue:Standby equity distribution agreement
Amount:$10 million
Tenor:Two years
Price:Higher of 93% of lowest daily volume-weighted average price of stock and $0.87
Warrants:No
Investor:YA Global Investments, LP
Fees:228,117 shares
Settlement date:March 3
Stock symbol:OTCBB: LTUS
Stock price:$1.41 at close March 3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.